Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Argus Health
Chinese Patent Office
Farmers Insurance

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for Patent: RE39128

« Back to Dashboard

Summary for Patent: RE39128

Title:Pleuromutilin derivatives as antimicrobials
Abstract:The present invention relates to pleuromutilin derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medical therapy, particularly antibacterial therapy.
Inventor(s): Berry; Valerie Joan (San Diego, CA), Dabbs; Steven (Harlow, GB), Frydrych; Colin Henry (Sawbridgeworth, GB), Hunt; Eric (Great Dunmow, GB), Sanderson; Francis Dominic (Harlow, GB), Woodnutt; Gary (San Diego, CA)
Assignee: SmithKline Beecham p.l.c. (Brentford, GB)
Application Number:10/631,707
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use; Dosage form;

No matches for this query

Foreign Priority and PCT Information for Patent: RE39128

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9722817Oct 29, 1997
United Kingdom9813689Jun 25, 1998
PCT Information
PCT FiledOctober 27, 1998PCT Application Number:PCT/GB98/03211
PCT Publication Date:May 06, 1999PCT Publication Number: WO99/21855

International Patent Family for Patent: RE39128

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina015987► Subscribe
Austria277925► Subscribe
Austria525373► Subscribe
Australia742167► Subscribe
Australia9636198► Subscribe
Brazil9814747► Subscribe
Canada2307551► Subscribe
China1205211► Subscribe
China1283197► Subscribe
Colombia5021129► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus